Literature DB >> 32709290

Vasopressin V2 receptor antagonists in autosomal dominant polycystic kidney disease: efficacy, safety, and tolerability.

Esther Meijer1, Ron T Gansevoort2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32709290     DOI: 10.1016/j.kint.2020.03.023

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  2 in total

1.  Perspectives on Drug Development in Early ADPKD.

Authors:  Djalila Mekahli; Hayley Womack; Neera K Dahl
Journal:  Clin J Am Soc Nephrol       Date:  2022-08-23       Impact factor: 10.614

Review 2.  Nephronophthisis-Pathobiology and Molecular Pathogenesis of a Rare Kidney Genetic Disease.

Authors:  Shabarni Gupta; Justyna E Ozimek-Kulik; Jacqueline Kathleen Phillips
Journal:  Genes (Basel)       Date:  2021-11-05       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.